BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34767651)

  • 1. Prompt response of advanced cutaneous squamous cell carcinoma to cemiplimab in a kidney transplant patient receiving treatment with everolimus.
    Gambichler T; Hessam S; Lüttringhaus T; Boms S
    Clin Exp Dermatol; 2022 Mar; 47(3):608-609. PubMed ID: 34767651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The successful use of pembrolizumab in a renal transplant recipient with metastatic melanoma.
    Hanna DL; Law SJ; Merrick SA; Heptinstall L; Bass P; Dupont P; Sheri A
    Melanoma Res; 2020 Jun; 30(3):321-324. PubMed ID: 31764435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial.
    Migden MR; Khushalani NI; Chang ALS; Lewis KD; Schmults CD; Hernandez-Aya L; Meier F; Schadendorf D; Guminski A; Hauschild A; Wong DJ; Daniels GA; Berking C; Jankovic V; Stankevich E; Booth J; Li S; Weinreich DM; Yancopoulos GD; Lowy I; Fury MG; Rischin D
    Lancet Oncol; 2020 Feb; 21(2):294-305. PubMed ID: 31952975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful Administration of Cemiplimab to a Patient With Advanced Cutaneous Squamous Cell Carcinoma After Renal Transplantation.
    Ali SA; Arman HE; Patel AA; Birhiray RE
    JCO Oncol Pract; 2020 Mar; 16(3):137-138. PubMed ID: 31770056
    [No Abstract]   [Full Text] [Related]  

  • 5. Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma.
    Hanna GJ; Dharanesswaran H; Giobbie-Hurder A; Harran JJ; Liao Z; Pai L; Tchekmedyian V; Ruiz ES; Waldman AH; Schmults CD; Riella LV; Lizotte P; Paweletz CP; Chandraker AK; Murakami N; Silk AW
    J Clin Oncol; 2024 Mar; 42(9):1021-1030. PubMed ID: 38252908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Pilot Study of Checkpoint Inhibitors in Solid Organ Transplant Recipients with Metastatic Cutaneous Squamous Cell Carcinoma.
    Tsung I; Worden FP; Fontana RJ
    Oncologist; 2021 Feb; 26(2):133-138. PubMed ID: 32969143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cemiplimab for locally advanced cutaneous squamous cell carcinoma: safety, efficacy, and position in therapy panel.
    Lebas E; Marchal N; Rorive A; Nikkels AF
    Expert Rev Anticancer Ther; 2021 Apr; 21(4):355-363. PubMed ID: 33554680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Checkpoint Inhibitors in a Kidney Transplant Recipient with Metastatic Cancer.
    Ong SC; Mannon RB
    Clin J Am Soc Nephrol; 2020 Aug; 15(8):1190-1192. PubMed ID: 32205320
    [No Abstract]   [Full Text] [Related]  

  • 9. RF-Cemiplimab: First Drug Approved for the Treatment of Metastatic or Unresectable Cutaneous Squamous Cell Carcinoma.
    Morgado-Carrasco D; Bosch-Amate X; Fustà-Novell X; Giavedoni P
    Actas Dermosifiliogr (Engl Ed); 2020 Mar; 111(2):161-163. PubMed ID: 31874704
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination regimens and immunologic mechanisms to enhance the efficacy of cemiplimab for cutaneous squamous cell carcinoma.
    Hanania HL; Lewis DJ
    Expert Rev Anticancer Ther; 2022 Feb; 22(2):237-238. PubMed ID: 34918605
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of metastatic cutaneous squamous cell carcinoma in a solid organ transplant recipient with programmed death-1 checkpoint inhibitor therapy.
    O'Connell KA; Schmults CD
    J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 1():45-48. PubMed ID: 34855241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid Life-Saving Response to Anti-PD-1 in a Solid Organ Transplant Recipient With Metastatic Cutaneous Squamous Cell Carcinoma: A Case Report and Review.
    Antonelli JP; Quach M; Mahajan A; Pleva J; Ma VT
    J Immunother; 2024 Jul-Aug 01; 47(6):216-219. PubMed ID: 38532708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safe Administration of Cemiplimab to a Kidney Transplant Patient with Locally Advanced Squamous Cell Carcinoma of the Scalp.
    Paoluzzi L; Ow TJ
    Curr Oncol; 2021 Jan; 28(1):574-580. PubMed ID: 33477979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Ipilimumab and Pembrolizumab in Metastatic Melanoma in a Combined Heart and Kidney Transplant Recipient: A Case Report.
    Soellradl I; Kehrer H; Cejka D
    Transplant Proc; 2020 Mar; 52(2):657-659. PubMed ID: 32044081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Checkpoint Inhibitors for Treating Advanced Cutaneous Squamous Cell Carcinoma.
    Patel R; Chang ALS
    Am J Clin Dermatol; 2019 Aug; 20(4):477-482. PubMed ID: 30737731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma.
    Villani A; Ocampo-Garza SS; Potestio L; Fabbrocini G; Ocampo-Candiani J; Ocampo-Garza J; Scalvenzi M
    Expert Opin Drug Saf; 2022 Jan; 21(1):21-29. PubMed ID: 34644510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.
    Migden MR; Rischin D; Schmults CD; Guminski A; Hauschild A; Lewis KD; Chung CH; Hernandez-Aya L; Lim AM; Chang ALS; Rabinowits G; Thai AA; Dunn LA; Hughes BGM; Khushalani NI; Modi B; Schadendorf D; Gao B; Seebach F; Li S; Li J; Mathias M; Booth J; Mohan K; Stankevich E; Babiker HM; Brana I; Gil-Martin M; Homsi J; Johnson ML; Moreno V; Niu J; Owonikoko TK; Papadopoulos KP; Yancopoulos GD; Lowy I; Fury MG
    N Engl J Med; 2018 Jul; 379(4):341-351. PubMed ID: 29863979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient.
    Vidovic D; Simms GA; Pasternak S; Walsh M; Peltekian K; Stein J; Helyer LK; Giacomantonio CA
    Front Immunol; 2021; 12():678028. PubMed ID: 34122442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cetuximab for treatment of advanced squamous cell carcinoma in solid organ transplant recipients.
    Boyd K; Shea SM; Patterson J
    Wien Med Wochenschr; 2013 Aug; 163(15-16):372-5. PubMed ID: 23800851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cemiplimab: A Review in Advanced Cutaneous Squamous Cell Carcinoma.
    Lee A; Duggan S; Deeks ED
    Drugs; 2020 Jun; 80(8):813-819. PubMed ID: 32306208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.